Search Results - "Lebuhotel, Celine"
-
1
Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia
Published in Nature communications (28-04-2022)“…Acute myeloid leukemia (AML) is a disease with high incidence of relapse that is originated and maintained from leukemia stem cells (LSCs). Hematopoietic stem…”
Get full text
Journal Article -
2
Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies
Published in Cancer research (Chicago, Ill.) (15-09-2015)“…Adoptive immunotherapy using autologous T cells endowed with chimeric antigen receptors (CAR) has emerged as a powerful means of treating cancer. However, a…”
Get full text
Journal Article -
3
Pre-TCRα supports CD3-dependent reactivation and expansion of TCRα-deficient primary human T-cells
Published in Molecular therapy. Methods & clinical development (01-01-2014)“…Chimeric antigen receptor technology offers a highly effective means for increasing the anti-tumor effects of autologous adoptive T-cell immunotherapy, and…”
Get full text
Journal Article -
4
Targeted gene therapy of xeroderma pigmentosum cells using meganuclease and TALEN
Published in PloS one (13-11-2013)“…Xeroderma pigmentosum group C (XP-C) is a rare human syndrome characterized by hypersensitivity to UV light and a dramatic predisposition to skin neoplasms…”
Get full text
Journal Article -
5
Chromosomal context and epigenetic mechanisms control the efficacy of genome editing by rare-cutting designer endonucleases
Published in Nucleic acids research (01-07-2012)“…The ability to specifically engineer the genome of living cells at precise locations using rare-cutting designer endonucleases has broad implications for…”
Get full text
Journal Article -
6
Efficient strategies for TALEN-mediated genome editing in mammalian cell lines
Published in Methods (San Diego, Calif.) (01-09-2014)“…TALEN is one of the most widely used tools in the field of genome editing. It enables gene integration and gene inactivation in a highly efficient and specific…”
Get full text
Journal Article -
7
Adoptive immunotherapy of acute myeloid leukemia (AML) with allogenic CAR t-cells targeting CD123
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
8
Down regulation of pRb in cultures of avian neuroretina cells promotes proliferation of reactive Müller-like cells and emergence of retinal stem/progenitors
Published in Experimental eye research (01-06-2010)“…The aim of this work was to define the role of pRb depletion in the proliferation and differentiation of avian retinoblasts in vitro. For this purpose vectors…”
Get full text
Journal Article -
9
Allogenic T-Cells Targeting CD123 for Adoptive Immunotherapy of Acute Myeloid Leukemia (AML)
Published in Blood (06-12-2014)“…Adoptive immunotherapy using autologous T-cells endowed with chimeric antigen receptors (CARs) has emerged as a promising new approach to treating cancer…”
Get full text
Journal Article -
10
Meganuclease-driven targeted integration in CHO-K1 cells for the fast generation of HTS-compatible cell-based assays
Published in Journal of biomolecular screening (01-09-2010)“…The development of cell-based assays for high-throughput screening (HTS) approaches often requires the generation of stable transformant cell lines. However,…”
Get more information
Journal Article -
11
Pre-T cell receptor for improved expansion of T cells in the absence of TCR alpha
Published in Molecular therapy (01-09-2013)“…Recent data have emerged from adoptive T-cell therapies where exogenous expression of a chimeric antigen receptor (CAR) has been shown to confer cancer…”
Get full text
Journal Article -
12
Down regulation of pRb in cultures of avian neuroretina cells promotes proliferation of reactive Mueller-like cells and emergence of retinal stem/progenitors
Published in Experimental eye research (01-06-2010)“…The aim of this work was to define the role of pRb depletion in the proliferation and differentiation of avian retinoblasts in vitro. For this purpose vectors…”
Get full text
Journal Article -
13
Pre-TCR[alpha] supports CD3-dependent reactivation and expansion of TCR[alpha]-deficient primary human T-cells
Published in Molecular therapy. Methods & clinical development (01-06-2014)“…Chimeric antigen receptor technology offers a highly effective means for increasing the anti-tumor effects of autologous adoptive T-cell immunotherapy, and…”
Get full text
Journal Article -
14
Targeted Gene Therapy of Xeroderma Pigmentosum Cells Using Meganuclease and TALEN(TM): e78678
Published in PloS one (01-11-2013)“…Xeroderma pigmentosum group C (XP-C) is a rare human syndrome characterized by hypersensitivity to UV light and a dramatic predisposition to skin neoplasms…”
Get full text
Journal Article -
15
419. Allogenic CAR T-Cells Targeting CD123 for Adoptive Immunotherapy of Acute Myeloid Leukemia (AML)
Published in Molecular therapy (01-05-2015)Get full text
Journal Article -
16
397. Allogenic CAR T-Cells Targeting CD123 Effectively Eliminate Myeloid Leukemia Cells
Published in Molecular therapy (01-05-2016)Get full text
Journal Article -
17
TCRab Deficient CAR T-Cells Targeting CD123: An Allogeneic Approach of Adoptive Immunotherapy for the Treatment of Acute Myeloid Leukemia (AML)
Published in Blood (03-12-2015)“…The remissions achieved using autologous T-cells expressing chimeric antigen receptors (CARs) in patients with advanced B cell leukemia and lymphomas have…”
Get full text
Journal Article -
18
Abstract 3992: Allogeneic TCRαβ-deficient CAR T-cells targeting CD123 effectively eliminate myeloid leukemia cells in vitro and in vivo PDX mice
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Acute myeloid leukemia (AML) is incurable in the majority of patients. While allogeneic stem cell transplantation remains the most effective therapy…”
Get full text
Journal Article -
19
Pre-T cell receptor for improved expansion of TCR alpha disrupted T cells
Published in Journal for immunotherapy of cancer (07-11-2013)“…Recent data have emerged from adoptive T-cell therapies where exogenous expression of a chimeric antigen receptor (CAR) has been shown to confer cancer…”
Get full text
Journal Article